Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
Source link
About The Author
GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million
Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
Source link